Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

NCT01110668 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumor

Interventions

DRUG: Nilotinib

Sponsor

Novartis Pharmaceuticals